StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SYMBIOX.BO$1.70+4.22%
Fair $1.70+0.0%

SYMBIOX.BO

Symbiox Investment & Trading Co Ltd

Consumer Cyclical / Textile ManufacturingBSE

$1.70

+0.07 (+4.22%)

Fairly Valued+0.0%Fair Value $1.70Fund rank 19/100 · Data gapFallback financials|
SA 24/D
F-Score: 4/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-30.7M · quality 27.7/100

Data gap 19/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 0/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is 0.6%, below the 5% threshold
Thesis & Journal · SYMBIOX.BOLocal privado en este navegador · Symbiox Investment & Trading Co Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$53M

P/E

27.9x

↑

EV/EBITDA

16.3x

↑

ROE

0.6%

↓

Gross Margin

23.5%

↓

Debt/Equity

N/A

•
52-Week Range$2
$1$4

TradingView lightweight chart

SYMBIOX.BO price, volumen y niveles de valoración

Último $1.730Periodo -86.8%
Fair value: $1.700

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+14.7%

FCF CAGR

—

FCF margin

129.6%

FCF / Net income

18.67x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $27.6M · net income $1.9M · FCF $35.8M

2022-FY → 2025-FY

Gross margin

23.5%-16.7% pts

Operating margin

9.2%-2.1% pts

Net margin

6.9%-0.6% pts

FCF margin

129.6%+148.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$27.6M$27.6M$39.0M$39.8M$18.3M
Net Income$1.9M$1.9M$2.1M$1.6M$1.4M
EBITDA$2.6M$2.6M$2.5M$2.2M$1.9M
EPS0.060.060.070.510.04
Gross Margin23.5%23.5%10.9%18.8%40.2%
Operating Margin9.2%9.2%0.5%7.5%11.4%
Net Margin6.9%6.9%5.3%4.0%7.6%
Balance Sheet
Current Ratio320.60320.60———
Cash Flow
Free Cash Flow$35.8M$35.8M$-30.7M$-44.7M$-3.5M
Returns
ROE0.6%0.6%0.7%0.5%0.4%
Valuation
P/E27.8727.8743.437.78147.12
EV/EBITDA16.3416.3434.9754.98107.84
P/B0.170.170.290.400.66
Growth & Yield
Revenue Growth-29.1%-29.1%-2.1%117.6%—
EPS Growth-9.0%-9.0%-86.8%1046.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

35.2%

muy exigente

EPS terminal req.

$0.15

Spread vs growth

-44.2%

5Y implied EPS CAGR

24.5%

exigente

EPS terminal req.

$0.18

Spread vs growth

-33.5%

10Y implied EPS CAGR

17.0%

exigente

EPS terminal req.

$0.29

Spread vs growth

-26.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -43.1%

Total return

-43.1%

Start / end P/E

45.4x → 28.4x

EPS bridge

0.07 → 0.06

Residual

+3.4%

EPS growth-9.0%
Multiple rerating-37.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term+3.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.